NIH funds two new biomedical technology resource centers

December 15, 2005

The National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), announced today that $18.2 million will be awarded to create two new biomedical technology resource centers to develop new image guided therapies and to further biochemistry studies of diseases such as alcoholism and cancer.

Brigham and Women's Hospital of Boston will receive $15 million over five years in a cooperative agreement to establish a national Image Guided Therapy (IGT) Center. The new resource will provide a unique, "one-stop-shopping" research, training, and service center that will develop and make available to scientists and clinicians image processing and display tools; dynamic and adaptive Magnetic Resonance Imaging methods; novel therapy techniques; and image-guided robotics. The funding will allow the IGT Center to expand its range of research areas to include cardiovascular interventions and targeted drug delivery.

"We believe this collaborative, multidisciplinary center will develop innovative image guided intervention technologies that will enable effective, less invasive clinical treatments that are not only more economical, but also produce better results for patients," said Barbara M. Alving, M.D., Acting Director of NCRR.

A portion of the $15 million in NIH support to the IGT resource will come from the National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering.

Through the second award, NCRR will provide Indiana University in Bloomington with $3.2 million over three years to launch the National Center for Glycomics and Glycoproteomics to advance the study of carbohydrate molecules. A relatively new field that uses sophisticated tools and methods, glycomics is the study of complex sugar molecules that are attached to many proteins and lipids found in the blood, on the surfaces of cells, and in other places in the human body. These sugar chains are critical to numerous processes from normal growth and development to the body's ability to fight infection. One way these molecules do their jobs is through subtle changes in their structures. A better understanding of these structures, how they work, and how changes in these molecules cause illness or are affected by medicines could lead to the discoveries of new treatments for a multitude of diseases.

"Until recently, glycobiology was an underappreciated and poorly understood discipline. Scientists' increasing ability to create model systems in which carbohydrate-related genes can be easily manipulated is allowing us, for the first time, to understand the function of these molecules in the context of complex systems. This flood of biological information is creating a great demand for analytical tools for the characterization of these systems, and this new center will provide critical resources to address that growing need," according to Michael Marron, Ph.D., NCRR's Director of Biomedical Technology Research and Research Resources.

The center will focus on effective coupling of high resolution molecular separations with mass spectrometry to generate a complete analytical system for high-sensitivity glycoprotein investigations. Its staff will facilitate collaborative investigations of glycoprotein markers associated with cancer and alcoholism; endocrinology-centered studies including fertilization; and comparative research involving plants and animals.

Educational activities will be conducted to disseminate developments in instrumentation and techniques to a wider audience via short courses, a seminar program, and graduate and postdoctoral training.
-end-
The National Center for Research Resources (NCRR) provides laboratory scientists and clinical researchers with environments and tools that they can use to prevent, detect, and treat a wide range of diseases. This support enables discoveries that begin at the molecular and cellular level, move to animal-based studies, and then are translated to patient-oriented clinical research, resulting in cures and treatments for both common and rare diseases. NCRR connects researchers with patients and communities across the nation to bring the power of shared resources and research to improve human health. For more information, visit www.ncrr.nih.gov.

NIH/National Center for Advancing Translational Sciences (NCATS)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.